4143121
doi
10.5281/zenodo.4143121
oai:zenodo.org:4143121
user-eu
G-DEFINER SOPs
Miceli, Rosalba
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
Clinical Oncology, Immunotherapy, Sex, Gender, Biology, Biostatistics. Bioinformatics
<p><strong><a href="https://gdefiner.net/">https://gdefiner.net/</a></strong></p>
<p><strong>Project: "Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment" </strong></p>
<p><strong>(G-DEFINER). </strong></p>
<p><strong>Project SOPs. </strong> <strong>(DOI of the Study Protocol: 10.5281/zenodo.6397628)</strong></p>
<p>This is a multicenter observational prospective clinical study aimed at investigating the inequalities between female (F) and male (M) patients in the development of immune-related adverse events (irAEs) associated with immunotherapy treatment. The evaluation of the differences in terms of irAEs incidence concerning biological aspects will be integrated by the exploration of their gender dimension.</p>
<p>These Standard Operating Procedures (SOPs) are documents containing detailed written instructions relating to common or important tasks and practices of the G-DEFINER project. G-DEFINER adopted the SOPs with the aim to achieve efficiency, quality output and uniformity during study conduction.</p>
Zenodo
2020-10-27
info:eu-repo/semantics/report
4143120
user-eu
award_title=ERA-NET Cofund Promoting Gender Equality in H2020 and the ERA; award_number=741874; award_identifiers_scheme=url; award_identifiers_identifier=https://cordis.europa.eu/projects/741874; funder_id=00k4n6c32; funder_name=European Commission;
1648653762.150302
253088
md5:f503387c9df7c16be8b78c6e831388a7
https://zenodo.org/records/4143121/files/SOP 04 - AE registration.pdf
220175
md5:8e00c5fa5b5344f4aa040447eb473276
https://zenodo.org/records/4143121/files/SOP 07 - Faeces sampling and microbiota analysis - 2.0 - 07.10.2019.pdf
209829
md5:ae2c113c1b9eac10c1b9bcf5b2e5ee02
https://zenodo.org/records/4143121/files/SOP 10 - Blood sampling and storing for cytokines.pdf
216059
md5:7d72490476ce9e277276450fe0d53414
https://zenodo.org/records/4143121/files/SOP 09 - Blood sampling and gene expression analysis - 2.0 - 07.10.2019.pdf
264789
md5:7ccc8e54b86543eecc5af023ddeee1aa
https://zenodo.org/records/4143121/files/SOP 02 - Data management CRF completion.pdf
224337
md5:f13084a57f4bfa8afc15875174e9f5c2
https://zenodo.org/records/4143121/files/SOP 08 - Blood sampling and SNP analysis.pdf
515156
md5:598ae54b6d435735e5630f37644733bf
https://zenodo.org/records/4143121/files/SOP 03 - Study conduct.pdf
217822
md5:1d04d066622efa2cf58052693fb659b2
https://zenodo.org/records/4143121/files/SOP 01 - Development, Approval and Review documents.pdf
public
10.5281/zenodo.4143120
isVersionOf
doi